Strides Pharma Science LtdStrides Pharma Science LtdStrides Pharma Science Ltd

Strides Pharma Science Ltd

No trades
No trades

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2026
Earnings, Q4 FY2026
Annual
May 18, 2026
Record profitability and ex-U.S. growth offset U.S. headwinds; outlook remains robust.
Earnings, Q3 FY2026
Jan 30, 2026
Profitability and ex-U.S. growth drove record margins and earnings, with robust cash flow.
Earnings, Q2 FY2026
Oct 31, 2025
Strong margin expansion and profitability, with robust growth in regulated markets.
Earnings, Q1 FY2026
Jul 29, 2025
Robust quarter with record profitability, strong U.S. growth, and reaffirmed long-term guidance.
2025
Earnings, Q4 FY2025
Annual
May 22, 2025
Strong FY25 results with robust growth, margin expansion, and increased R&D investment.
Earnings, Q3 FY2025
Jan 30, 2025
Q3 saw strong growth, margin expansion, and debt reduction, supporting FY25 guidance.
Earnings, Q2 FY2025
Oct 24, 2024
Record EBITDA and 17% revenue growth drive robust outlook, led by U.S. and CDMO segments.
Earnings, Q1 FY2025
Jul 29, 2024
Record Q1 revenue, 20% EBITDA margin, and strong U.S. growth drive FY25 confidence.
2024
Earnings, Q4 FY2024
Annual
May 22, 2024
Earnings, Q3 FY2024
Jan 30, 2024
Earnings, Q2 FY2024
Oct 30, 2023
Earnings, Q1 FY2024
Aug 2, 2023
2023
Earnings, Q4 FY2023
May 25, 2023
Earnings, Q3 FY2023
Jan 24, 2023
Earnings, Q2 FY2023
Nov 14, 2022
Earnings, Q1 FY2023
Jul 29, 2022
2022
Earnings, Q4 FY2022
May 25, 2022
Earnings, Q3 FY2022
Feb 10, 2022
Earnings, Q2 FY2022
Nov 10, 2021
Earnings, Q1 FY2022
Aug 6, 2021